Effects of peroxisome proliferator-activated receptor-γ agonists on central nervous system inflammation
✍ Scribed by Tammy Kielian; Paul D. Drew
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 225 KB
- Volume
- 71
- Category
- Article
- ISSN
- 0360-4012
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Peroxisome proliferator‐activated receptor‐γ (PPAR‐γ) plays a critical role in glucose and lipid metabolism. More recently, PPAR‐γ ligands have been reported to inhibit the expression of proinflammatory molecules by monocytes/macrophages. Of relevance to CNS disease is that PPAR‐γ agonists have been demonstrated to have similar effects on microglia. PPAR‐γ agonists also ameliorate experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis. This Mini‐Review summarizes the effects of PPAR‐γ agonists in mediating immune responses and the potential of these agonists in the treatment of inflammatory disorders of the CNS. © 2002 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
During drug metabolism, UDPglucuronate, a product of the reaction catalyzed by the enzyme UDPglucose dehydrogenase (UGDH), is conjugated with the metabolites to facilitate their elimination. So far, it is not known whether xenobiotics can modulate the UGDH gene expression. This question was tested b